Showing 1 - 5 results of 5 for search 'Katrine Finderup Nielsen', query time: 0.03s Refine Results
  1. 1
    Vaccine effectiveness against SARS-CoV-2 infection, hospitalization, and death when combining a first dose ChAdOx1 vaccine with a subsequent mRNA vaccine in Denmark: A nationwide population-based cohort study.

    Vaccine effectiveness against SARS-CoV-2 infection, hospitalization, and death when combining a first dose ChAdOx1 vaccine with a subsequent mRNA vaccine in Denmark: A nationwide p... by Mie Agermose Gram, Jens Nielsen, Astrid Blicher Schelde, Katrine Finderup Nielsen, Ida Rask Moustsen-Helms, Anne Katrine Bjørkholt Sørensen, Palle Valentiner-Branth, Hanne-Dorthe Emborg

    Published 2021-12-01
    Get full text
    Article
  2. 2
    Follow-Up Study of Effectiveness of 23-Valent Pneumococcal Polysaccharide Vaccine Against All-Type and Serotype-Specific Invasive Pneumococcal Disease, Denmark

    Follow-Up Study of Effectiveness of 23-Valent Pneumococcal Polysaccharide Vaccine Against All-Type and Serotype-Specific Invasive Pneumococcal Disease, Denmark by Katrine Finderup Nielsen, Lise Birk Nielsen, Tine Dalby, Frederikke Kristensen Lomholt, Hans-Christian Slotved, Kurt Fuursted, Zitta Barrella Harboe, Charlotte Sværke Jørgensen, Palle Valentiner-Branth

    Published 2024-06-01
    Get full text
    Article
  3. 3
    Vaccine effectiveness against SARS-CoV-2 reinfection during periods of Alpha, Delta, or Omicron dominance: A Danish nationwide study.

    Vaccine effectiveness against SARS-CoV-2 reinfection during periods of Alpha, Delta, or Omicron dominance: A Danish nationwide study. by Katrine Finderup Nielsen, Ida Rask Moustsen-Helms, Astrid Blicher Schelde, Mie Agermose Gram, Hanne-Dorthe Emborg, Jens Nielsen, Christian Holm Hansen, Michael Asger Andersen, Marianna Meaidi, Jan Wohlfahrt, Palle Valentiner-Branth

    Published 2022-11-01
    Get full text
    Article
  4. 4
    Vaccine effectiveness against SARS-CoV-2 reinfection during periods of Alpha, Delta, or Omicron dominance: A Danish nationwide study

    Vaccine effectiveness against SARS-CoV-2 reinfection during periods of Alpha, Delta, or Omicron dominance: A Danish nationwide study by Katrine Finderup Nielsen, Ida Rask Moustsen-Helms, Astrid Blicher Schelde, Mie Agermose Gram, Hanne-Dorthe Emborg, Jens Nielsen, Christian Holm Hansen, Michael Asger Andersen, Marianna Meaidi, Jan Wohlfahrt, Palle Valentiner-Branth

    Published 2022-11-01
    Get full text
    Article
  5. 5
    Vaccine effectiveness against SARS-CoV-2 infection or COVID-19 hospitalization with the Alpha, Delta, or Omicron SARS-CoV-2 variant: A nationwide Danish cohort study.

    Vaccine effectiveness against SARS-CoV-2 infection or COVID-19 hospitalization with the Alpha, Delta, or Omicron SARS-CoV-2 variant: A nationwide Danish cohort study. by Mie Agermose Gram, Hanne-Dorthe Emborg, Astrid Blicher Schelde, Nikolaj Ulrik Friis, Katrine Finderup Nielsen, Ida Rask Moustsen-Helms, Rebecca Legarth, Janni Uyen Hoa Lam, Manon Chaine, Aisha Zahoor Malik, Morten Rasmussen, Jannik Fonager, Raphael Niklaus Sieber, Marc Stegger, Steen Ethelberg, Palle Valentiner-Branth, Christian Holm Hansen

    Published 2022-09-01
    Get full text
    Article

Search Tools: